Functional modulation on macrophage by low dose naltrexone (LDN)

Int Immunopharmacol
October 2016
https://www.ncbi.nlm.nih.gov/pubmed/27561742

Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/

Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis

Exp Biol Med (Maywood)
November 2009
https://pubmed.ncbi.nlm.nih.gov/19855075/

Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment

BMJ Case Reports
January 2018
https://casereports.bmj.com/content/2018/bcr-2017-221405

The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial

J Dermatolog Treat
08 June 2020
https://pubmed.ncbi.nlm.nih.gov/32449418/

Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function

Altern Ther Health Med
05 November 2013
http://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf

Low-dose Naltrexone Therapy for Psoriasis

Int J Pharm Compd
Mar-Apr 2020
https://pubmed.ncbi.nlm.nih.gov/32196470/

Treating chronic pain with low dose naltrexone and ultralow dose naltrexone: a review paper

Journal of Pain Management and Therapy
01 February 2019
https://www.alliedacademies.org/articles/treating-chronic-pain-with-low-dose-naltrexone-and-ultralow-dose-naltrexonea-review-paper-11183.html

Low-Dose Naltrexone reduces symptoms in Stiff-Person Syndrome

Med Hypotheses
April 2020
https://pubmed.ncbi.nlm.nih.gov/31954293/